Cargando…
A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC
BACKGROUND: Most patients with high-grade serous ovarian cancer (HGSOC) experienced disease recurrence with cumulative chemoresistance, leading to treatment failure. However, few biomarkers are currently available in clinical practice that can accurately predict chemotherapy response. The tumor immu...
Autores principales: | Xi, Yue, Zhang, Yingchun, Zheng, Kun, Zou, Jiawei, Gui, Lv, Zou, Xin, Chen, Liang, Hao, Jie, Zhang, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382026/ https://www.ncbi.nlm.nih.gov/pubmed/37519793 http://dx.doi.org/10.3389/fonc.2023.1171582 |
Ejemplares similares
-
Progesterone prevents HGSOC by promoting precancerous cell pyroptosis via inducing fibroblast paracrine
por: Wu, Nayiyuan, et al.
Publicado: (2023) -
MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
por: Sun, Chenggong, et al.
Publicado: (2020) -
Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib
por: Eismann, Julia, et al.
Publicado: (2019) -
3D dynamic cultures of HGSOC organoids to model innovative and standard therapies
por: Cavarzerani, Enrico, et al.
Publicado: (2023) -
Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis
por: Pavlič, Renata, et al.
Publicado: (2022)